Actavis Pharma Inc.
Actavis Pharma Inc., a prominent player in the global pharmaceutical industry, is headquartered in the United States. Founded in 1984, the company has established itself as a leader in generic and specialty pharmaceuticals, focusing on areas such as central nervous system disorders, cardiovascular health, and infectious diseases.
With a robust portfolio of core products, Actavis is renowned for its commitment to quality and innovation, offering a wide range of generic medications that provide cost-effective alternatives to brand-name drugs. The company has achieved significant milestones, including strategic acquisitions that have expanded its market presence and product offerings.
Actavis Pharma Inc. continues to strengthen its position in the competitive pharmaceutical landscape, recognised for its dedication to improving patient access to essential medications while maintaining high standards of safety and efficacy.
+16 vs industry average
Actavis Pharma Inc.’s score of 54 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Actavis Pharma Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Actavis Pharma Inc. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Actavis Pharma Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Actavis Pharma Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Teva Pharmaceutical Industries Limited
Carbon Disclosure Project
Inherited from Teva Pharmaceutical Industries LimitedThe Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project